{"id":329770,"date":"2021-03-16T12:38:02","date_gmt":"2021-03-16T11:38:02","guid":{"rendered":"https:\/\/medizinonline.com\/un-ginecologo-y-un-oncologo-hablan-sobre-el-cancer-de-ovario\/"},"modified":"2021-03-16T12:38:02","modified_gmt":"2021-03-16T11:38:02","slug":"un-ginecologo-y-un-oncologo-hablan-sobre-el-cancer-de-ovario","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/un-ginecologo-y-un-oncologo-hablan-sobre-el-cancer-de-ovario\/","title":{"rendered":"Un ginec\u00f3logo y un onc\u00f3logo hablan sobre el c\u00e1ncer de ovario"},"content":{"rendered":"<p>Aunque el pron\u00f3stico de las pacientes con c\u00e1ncer de ovario ha mejorado en los \u00faltimos a\u00f1os, sigue siendo el tumor ginecol\u00f3gico m\u00e1s mort\u00edfero [1, 2]. En la entrevista en v\u00eddeo, el ginec\u00f3logo Prof. Dr. med. Andreas G\u00fcnthert y la onc\u00f3loga Dra. med. D\u00e9sir\u00e9e Gassmann dan su valoraci\u00f3n de la situaci\u00f3n actual de las pacientes con c\u00e1ncer de ovario y tambi\u00e9n arrojan luz sobre los efectos de la pandemia del Covid-19.<\/p>\n<p> <!--more--> <\/p>\n<p>En conversaci\u00f3n: Prof. Dr. med. Andreas G\u00fcnthert, especialista en ginecolog\u00eda y obstetricia, y Dra. med. D\u00e9sir\u00e9e Gassmann, especialista en medicina interna general y especialista en oncolog\u00eda m\u00e9dica del gyn-zentrum Luzern (www.gyn-zentrum.ch)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><iframe frameborder=\"0\" height=\"360\" data-src=\"https:\/\/player.vimeo.com\/video\/524236915\" width=\"640\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n<p>Experiencia con pacientes de c\u00e1ncer de ovario durante la pandemia de Covid-19<\/p>\n<p><iframe frameborder=\"0\" height=\"360\" data-src=\"https:\/\/player.vimeo.com\/video\/524237598\" width=\"640\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n<p>Las entrevistas reflejan las opiniones personales e independientes del Prof. G\u00fcnthert y del Dr. Gassmann. GlaxoSmithKline AG no tiene ninguna influencia sobre el contenido.<\/p>\n<p>Responsable del contenido y financiado por GlaxoSmithKline AG, Talstr. 3 &#8211; 5, 3053 M\u00fcnchenbuchsee.<\/p>\n<p>Las marcas registradas pertenecen a sus respectivos propietarios. \u00a92020 Grupo de empresas GSK o su licenciante.<\/p>\n<p><a href=\"https:\/\/assets.medizinonline.com\/sites\/default\/files\/201210_zejula_kurz-fi_d_10205.pdf\" target=\"_blank\" rel=\"noopener\">Breve informaci\u00f3n tem\u00e1tica Zejula<\/a><\/p>\n<p>PM-CH-NRP-ADVR-210013-02\/2021<\/p>\n<p><strong>Literatura<\/strong><\/p>\n<p>1. Wu, J., et al, Mejora de la supervivencia en el c\u00e1ncer de ovario, con aumento de las diferencias de supervivencia de razas y estatus socioecon\u00f3mico: un an\u00e1lisis de periodo, 1983-2012. J Cancer, 2018. 9(19): p. 3548-3556.<\/p>\n<p>2 Buechel, M., et al, Tratamiento de las pacientes con c\u00e1ncer de ovario epitelial recidivante para las que el platino sigue siendo una opci\u00f3n. Ann Oncol, 2019. 30(5): p. 721-732.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aunque el pron\u00f3stico de las pacientes con c\u00e1ncer de ovario ha mejorado en los \u00faltimos a\u00f1os, sigue siendo el tumor ginecol\u00f3gico m\u00e1s mort\u00edfero [1, 2]. En la entrevista en v\u00eddeo,&hellip;<\/p>\n","protected":false},"author":12,"featured_media":104147,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Gesti\u00f3n terap\u00e9utica interdisciplinar","footnotes":""},"category":[11369,11336,11552],"tags":[],"powerkit_post_featured":[],"class_list":["post-329770","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ginecologia","category-oncologia","category-rx-es","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-14 07:47:30","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/329770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=329770"}],"version-history":[{"count":0,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/329770\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/104147"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=329770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=329770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=329770"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=329770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}